Development of a Pharmacoeconomic Model to Assess the Cost Effectiveness of Pharmacogenomics Tests in Chronic Heart Failure- The Case of Ivabradine
Abstract
Authors
AC Iliza F Fanton Aita D Mitchell JR Guertin A Matteau J Lelorier